Jeff Lagasse

Mylan CEO Heather Bresch calls new option "an extraordinary commercial response" following rising backlash from public, lawmakers on price hike.

A pair of state-specific studies suggest that, after the implementation of the Affordable Care Act, emergency rooms saw more patients, while staffing fewer on-call specialists.

With scores of political offices in contention during this year's election, healthcare remains a complex and hotly debated issue -- prompting the Council of Accountable Physician Practices to issue a primer for candidates, detailing what the group has identified as the three most important health policy considerations.

Middle-class people in Medicaid expansion states fared better with insurance premium costs than those in non-expansion states. That's the word from a new study by the Department of Health and Human Services.

Latest round of negotiations between nurses and Allina Health ended on Tuesday with no agreement. The strike is set to start on Labor Day.

Despite dip in statewide margin, 80 percent of the state's 65 hospitals are ending the year with a net profit, a new report shows.

Responding to pressure from lawmakers and the public, Mylan Pharmaceutical is expanding existing programs to make its EpiPen emergency allergy treatments more affordable.

Orlando Health and Florida Hospital will waive $5.5 million in costs and continue to help victims with financial assistance for follow-up care.

Lawmakers are imploring Mylan Pharmaceutical, the manufacturer of EpiPens, to scale back price increases that have seen the cost of the life-saving emergency allergy treatment swell from $100 to $600 per package, according to published reports.

If the poorest areas utilized healthcare at the rate of the most affluent, overall utilization and spending could be as much as 30 percent less, according to a new book published by the late Richard Cooper, MD.